Lexogen Achieves Recognition as One of Austria's Top Innovators
Lexogen, a leading force in the field of RNA sequencing and transcriptome analysis, has earned its place among Austria's top innovative companies. This prestigious recognition comes from esteemed sources such as Statista and the business magazine trend. It underscores Lexogen's significant contributions to the life sciences sector.
A Closer Look at Lexogen's Innovations
This annual ranking highlights companies that demonstrate exceptional creativity, technological advancements, and a progressive corporate culture. The evaluation involves a wide network of experts, showcasing Lexogen's commitment to high-quality development and research.
Driving Life Sciences Forward Through Innovation
Founded nearly two decades ago, Lexogen is on a mission to help scientists gain deeper insights into gene functionality. Through the development of pioneering technologies, the company enables comprehensive RNA analysis, which is vital for various fields, including healthcare. Their solutions facilitate groundbreaking research and applications, particularly in areas such as drug discovery and personalized medicine.
Commitment to Quality and Safety
With a strong emphasis on maintaining the highest standards, all of Lexogen's products are developed and manufactured in-house in Vienna, adhering to ISO 9001:2015 and ISO 13485:2016 certifications. This stringent process ensures that Lexogen’s offerings meet diagnostic-grade quality assurance. Their impressive portfolio includes 17 patent families that safeguard innovations essential to RNA research.
Global Reach and Collaborations
Operating globally, Lexogen has established a subsidiary in the United States and over 30 distributors worldwide. This extensive network ensures that innovative technologies are accessible to scientists in more than 60 countries, empowering researchers to push the boundaries of scientific exploration.
Fostering a Culture of Innovation
Innovation at Lexogen goes beyond product development; it's ingrained in the company's culture. Stéphane Barges, the CEO of Lexogen, emphasizes that core values drive their collaboration and achievements. He states, "Innovation creates value built on trust and empowerment." This mindset enables team members to explore new ideas and support each other while fostering a nurturing environment for creativity and learning.
About Lexogen
Lexogen specializes in RNA sequencing and develops innovative solutions to study gene expression, providing crucial insights into transcriptomics. Their comprehensive services and advanced products cater to both research and diagnostic applications, ensuring consistent reliability and accuracy in results.
As a recognized leader in its field, Lexogen continues to strive for excellence, making it a trusted name in biotechnology. With their commitment to innovation and quality, Lexogen is well-positioned to lead advancements in genetic research and medical diagnostics.
Frequently Asked Questions
What is Lexogen known for?
Lexogen is known for its pioneering work in RNA sequencing and transcriptome analysis, providing advanced technologies for life science research.
How does Lexogen maintain quality in its products?
All products are developed in-house in Vienna, in compliance with ISO certifications, ensuring diagnostic-grade quality and reliability.
Where does Lexogen operate globally?
Lexogen operates in over 60 countries, with a subsidiary in the United States and more than 30 distributors worldwide.
What role does innovation play at Lexogen?
Innovation is central to Lexogen’s culture, driving collaboration and development, as well as fostering a supportive environment for new ideas.
What impact does Lexogen make in the healthcare sector?
Lexogen's solutions support critical research in drug discovery and personalized medicine, aiding in the diagnosis and treatment of diseases.
